fluoxetine has been researched along with Atrophy in 8 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To further explore the underlying antidepressant mechanism of ginseng total saponins (GTS), this study observed the effects on hippocampal astrocyte structural plasticity and hippocampal volume in the corticosterone-induced mouse depression model." | 7.85 | Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy. ( Chen, L; Dai, JG; Huang, YF; Lin, ZX; Wang, X; Zhao, YN, 2017) |
| "To study the effect of fluoxetine on dendrite atrophy of hippocampal neurons in rat depression model." | 7.71 | Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. ( Luo, L; Tan, RX, 2001) |
| "To further explore the underlying antidepressant mechanism of ginseng total saponins (GTS), this study observed the effects on hippocampal astrocyte structural plasticity and hippocampal volume in the corticosterone-induced mouse depression model." | 3.85 | Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy. ( Chen, L; Dai, JG; Huang, YF; Lin, ZX; Wang, X; Zhao, YN, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 2 |
| Wang, X | 1 |
| Lin, ZX | 1 |
| Dai, JG | 1 |
| Huang, YF | 1 |
| Zhao, YN | 1 |
| Zhao, Y | 1 |
| Lin, Z | 1 |
| Ouyang, L | 1 |
| Gu, L | 1 |
| Chen, F | 1 |
| Zhang, Q | 1 |
| Morais, M | 1 |
| Santos, PA | 1 |
| Mateus-Pinheiro, A | 1 |
| Patrício, P | 1 |
| Pinto, L | 1 |
| Sousa, N | 1 |
| Pedroso, P | 1 |
| Almeida, S | 1 |
| Filipe, A | 1 |
| Bessa, JM | 1 |
| Jin, P | 1 |
| Yu, HL | 1 |
| Zhang, F | 1 |
| Quan, ZS | 1 |
| Fontenelle, LF | 1 |
| Leite, MA | 1 |
| Hoexter, MQ | 1 |
| Dougherty, DD | 1 |
| Shavitt, RG | 1 |
| D'Alcante, CC | 1 |
| Duran, FL | 1 |
| Lopes, AC | 1 |
| Diniz, JB | 1 |
| Batistuzzo, MC | 1 |
| Evans, KC | 1 |
| Bressan, RA | 1 |
| Busatto, GF | 1 |
| Miguel, EC | 1 |
| Mendhekar, DN | 1 |
| Luo, L | 1 |
| Tan, RX | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Randomized Open Trial for Any Patient.[NCT00680602] | Phase 4 | 158 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fluoxetine and Atrophy
| Article | Year |
|---|---|
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
Topics: Adult; Atrophy; Cognitive Behavioral Therapy; Female; Fluoxetine; Humans; Male; Nerve Fibers, Unmyel | 2013 |
7 other studies available for fluoxetine and Atrophy
| Article | Year |
|---|---|
Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy.
Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depression; Disease Models, Ani | 2017 |
Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam.
Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depressive Disorder; Diazepam; | 2018 |
The effects of chronic stress on hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibition.
Topics: Animals; Atrophy; Carbazoles; Dendrites; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; | 2014 |
Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Antioxidants; Atrophy; Brain-Derived Ne | 2015 |
Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
Topics: Adult; Antipsychotic Agents; Atrophy; Caudate Nucleus; Clonazepam; Clozapine; Dibenzothiazepines; El | 2008 |
Fluoxetine-induced breast atrophy.
Topics: Adult; Atrophy; Breast; Dysthymic Disorder; Female; Fluoxetine; Humans; Selective Serotonin Reuptake | 2004 |
Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Atrophy; Dendrites; Depression; Fluoxetine; Hippo | 2001 |